Al Mojil Drug Co.
Al Mojil Drug Co. is a Kuwait-based pharmaceutical and healthcare distributor, founded 1961, that distributes pharmaceuticals, nutrition, diagnostics, consumer health, and veterinary products to hospitals, pharmacies, retailers, and government ministries through five divisions and 1,000+ SKUs.
- Company typePrivate
- Founded1961
- HeadquartersSafat, Kuwait
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Al Mojil Drug Co. does
Al Mojil Drug Co. (K.S.C.C.) is a privately held Kuwaiti pharmaceutical and healthcare distribution company founded in 1961, operating as a closed Kuwait Shareholding Company headquartered at Al Sanabil Tower, Sharq, Kuwait City. The company distributes pharmaceuticals, nutritional products, veterinary medicines, consumer health items, and laboratory and diagnostic medical equipment through five divisions: Pharmaceuticals (established 1964, the largest), Consumer Health (1973), Nutrition (2000), Lab and Diagnostics (2000), and Veterinary (2000). It serves hospitals, pharmacies, diagnostic laboratories, retail chains (Lulu Hypermarket, Hypermax), government ministries (Ministry of Interior, healthcare ministries), and enterprise customers such as Kuwait Oil Company across Kuwait.
Al Mojil's operating model is B2B distribution built on exclusive or core supplier partnerships with multinational pharmaceutical and medical equipment manufacturers including Novartis, AstraZeneca, Abbott, Sandoz, Viatris, Janssen (Johnson & Johnson), Biogen, Vertex, Allergan (AbbVie), Astellas, MSD (Merck), Thermo Fisher Scientific, and Baxter. Revenue mechanics are transactional, quote-based distribution negotiated directly with healthcare providers, pharmacies, hospitals, and government entities; no public pricing is disclosed. Supporting services include a Patient Support Program, a Charity Unit facilitating access to cancer therapies, and a pharmacovigilance reporting system aligned with regulatory standards.
The technology and infrastructure layer is built on SAP One ERP integrated with Microsoft and Cisco IT systems, two temperature-controlled warehouses exceeding 6,000 m² (with three precision chillers at 2–8°C and a dedicated 20°C freezer), 15 specialized refrigerated vehicles (1- to 8-ton) monitored via the Wialon tracking system with real-time location, temperature, and humidity telemetry, and IoT-enabled 24/7 cold chain monitoring. The company holds ISO 9001:2015 and EU-aligned GDP (Good Distribution Practice) certifications and maintains an active conference presence in Kuwait's specialist medical community.
Al Mojil Drug Co. firmographics
Firmographics- Name
- Al Mojil Drug Co.
- Legal name
- Al Mojil Drug Co. (K.S.C.C.)
- Website
- https://mojildrug.com
- Company type
- Private
- Founded year
- 1961
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Al Mojil Drug Co. is a Kuwait-based pharmaceutical and healthcare distributor, founded 1961, that distributes pharmaceuticals, nutrition, diagnostics, consumer health, and veterinary products to hospitals, pharmacies, retailers, and government ministries through five divisions and 1,000+ SKUs.
- Ownership category
- akta.pro rank
Al Mojil Drug Co. industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industries
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL), Specialty Pharmaceutical Distributors (HLAIAJAB)
Keywords
Where Al Mojil Drug Co. is headquartered
LocationHeadquarters
- HQ city
- Safat
- HQ country
- Kuwait
- HQ region
- Middle East
Offices2 records
Markets served
Al Mojil Drug Co. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Distribution: Distribution of pharmaceutical products as the major division established in 1964. Strategic partnerships with leading multinational pharmaceutical companies bringing trusted global innovations to Kuwait.
- Lab and Diagnostics Distribution: Distribution of advanced diagnostic tools and medical equipment as the third largest division established in 2000.
- Nutrition Products Distribution: Distribution of nutritional products including infant formulas, clinical and adult nutrition from trusted global brands.
- Consumer Health Products Distribution: Distribution of over-the-counter wellness products, personal care items, and everyday health essentials. Division established in 1973 with around 100 products.
- Veterinary Products Distribution: Distribution of veterinary medicines, vaccines, and nutritional products for companion animals and livestock.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Al Mojil Drug Co. product offering
Product offeringCore offering
Al Mojil Drug Company is a Kuwait-based diversified healthcare products distributor that imports, warehouses, and distributes pharmaceuticals, nutrition products, medical and diagnostic equipment, consumer health products, and veterinary medicines from leading global manufacturers to hospitals, pharmacies, laboratories, retail chains, and government healthcare ministries across Kuwait.
Product overview
Al Mojil Drug Company operates as a diversified pharmaceutical and healthcare distribution company with a five-division structure: Pharmaceuticals (established 1964), Nutrition, Lab and Diagnostics, Consumer Health, and Veterinary divisions. The company distributes over 1,000 trusted health products across Kuwait to clinics, hospitals, pharmacies, labs, supermarkets, hypermarkets, and ministries through a combination of commercial partnerships with multinational companies and direct distribution. Supporting operations include pharmacovigilance reporting services, patient support programs, charity initiatives for life-saving treatments, and temperature-controlled warehouse and fleet logistics infrastructure.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceuticals Division Distribution of branded and specialty pharmaceutical products from global manufacturers (e.g., Novartis, AstraZeneca, MSD, Janssen) to hospitals, pharmacies, and Patient Support Programs in Kuwait, including cancer therapies through its Charity Unit.
- Nutrition Division Distribution of nutritional products, including infant formulas, clinical nutrition, and adult nutrition from trusted global brands, to hospitals, pharmacies, and retail channels in Kuwait.
- Lab and Diagnostics Division Distribution of advanced diagnostic tools and medical equipment, including laboratory supplies, supported by professional guidance and training for healthcare providers in Kuwait.
- Consumer Health Division Distribution of over-the-counter wellness products, personal care items, and everyday health essentials to pharmacies and retail chains across Kuwait, with approximately 100 products in the portfolio.
- Veterinary Division Distribution of veterinary medicines, vaccines, and nutritional products for companion animals and livestock to veterinary practices and livestock operations in Kuwait.
- Pharmacovigilance Services
Quantifiable outcome
- Over 1000 trusted health products distributed across Kuwait
- +2 more outcomes
Companies that use Al Mojil Drug Co.
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles6 records
Al Mojil Drug Co. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Al Mojil Drug Co. partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core.
- NovartiscorePharmaceutical supplier partner distributing Novartis pharmaceutical products in Kuwait market.
- AstraZenecacorePharmaceutical supplier partner distributing AstraZeneca products in Kuwait.
- AbbottcorePharmaceutical supplier partner including Abbott Pharma, Abbot Molecular, and Abbott Diagnostics divisions.
- SandozcorePharmaceutical supplier partner distributing generic pharmaceutical products.
- ViatriscorePharmaceutical supplier partner distributing Viatris products in Kuwait.
- JanssencorePharmaceutical supplier partner (Johnson & Johnson subsidiary) distributing innovative medicines.
- BiogencorePharmaceutical supplier partner specializing in neurological and biotechnology products.
- VertexcorePharmaceutical supplier partner specializing in cystic fibrosis and other serious diseases treatments.
- AllergancorePharmaceutical supplier partner (AbbVie subsidiary) distributing eye care and medical aesthetics products.
- AstellascoreJapanese pharmaceutical company supplier partner.
- Thermo Fisher ScientificcoreLab and diagnostics equipment supplier partner.
- BaxtercoreMedical equipment and pharmaceutical products supplier.
- MSDcorePharmaceutical supplier partner (Merck & Co. outside US/Canada).
- MicrosoftcoreIT infrastructure partner providing cloud and enterprise technology solutions for SAP One ERP system and business operations.
- CiscocoreIT infrastructure partner providing networking, security, and communication technology for reliable, scalable systems.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Al Mojil Drug Co. competitors and assessment
Company assessmentBroad incumbents
- Gulf Pharmaceutical Industries (Julphar): UAE-headquartered pharmaceutical manufacturer and distributor serving the GCC and MENA; comparable to Al Mojil in regional pharma distribution, though broader in scale and vertically integrated into manufacturing.
- Tabuk Pharmaceuticals: Saudi pharma manufacturer and distributor; relevant peer given parallel focus on branded generics, specialty Rx, and distribution partnerships with multinationals across the MENA region.
- Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO): Saudi pharma manufacturer and distributor covering branded generics, Rx, and consumer health; a broader incumbent in the same Gulf pharmaceutical distribution space as Al Mojil.
- Hikma Pharmaceuticals: Jordan-headquartered multinational manufacturer and distributor of branded and generic pharmaceuticals across MENA; overlaps with Al Mojil's specialty and branded Rx distribution portfolio in the region.
- Astra Industrial Group: Saudi conglomerate with pharmaceutical manufacturing and distribution operations; comparable to Al Mojil in serving GCC hospital and pharmacy channels with multinational-licensed products.
Regional players
- BinDawood Holding: Saudi retail and pharmacy operator (Bindawood, Danube, BinDawood pharmacies); comparable to the retail and consumer health distribution segment in which Al Mojil supplies consumer health products to hypermarkets.
- Al Hammadi Holding: Saudi hospital and healthcare services operator; relevant peer for understanding demand-side procurement patterns in GCC hospitals that Al Mojil supplies through its Rx and medical equipment divisions.
- Al-Nahdi Medical Company: Saudi Arabia's largest pharmacy retail chain; comparable to Al Mojil's Consumer Health and pharmacy distribution business, serving a similar B2B-to-B2C downstream pharmacy channel but operating retail rather than wholesale.
- Dallah Healthcare Holding: Saudi healthcare services and hospital operator; overlaps with Al Mojil's hospital customer base and pharmaceutical supply dynamics, though oriented to operational healthcare rather than distribution.
Direct peers
- Tamer Group: Saudi-based pharmaceutical distribution and consumer health company; one of the largest pharma distributors in the GCC, with a multi-division model (pharma, consumer, nutrition) closely comparable to Al Mojil's five-division structure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Al Mojil Drug Co. social profiles
Digital presenceAl Mojil Drug Co. compliance and trust
Trust signalCompliance2 records
Al Mojil Drug Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Al Mojil Drug Co. leadership team
Management profileNumber of profiles
Al Mojil Drug Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Al Mojil Drug Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Al Mojil Drug Co.
What does Al Mojil Drug Co. do?
Al Mojil Drug Company is a Kuwait-based diversified healthcare products distributor that imports, warehouses, and distributes pharmaceuticals, nutrition products, medical and diagnostic equipment, consumer health products, and veterinary medicines from leading global manufacturers to hospitals, pharmacies, laboratories, retail chains, and government healthcare ministries across Kuwait.
Is Al Mojil Drug Co. a public or private company?
Al Mojil Drug Co. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Al Mojil Drug Co. founded?
Al Mojil Drug Co. was founded in 1961. It employs 501 to 1,000 people.
Where is Al Mojil Drug Co. based?
Al Mojil Drug Co. is headquartered in Safat, Kuwait, in the Middle East region.
How does Al Mojil Drug Co. make money?
Five revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are lab and Diagnostics Distribution, nutrition Products Distribution, consumer Health Products Distribution and veterinary Products Distribution.
Who are Al Mojil Drug Co.'s main competitors?
Broad incumbents on record are Gulf Pharmaceutical Industries (Julphar), Tabuk Pharmaceuticals, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Hikma Pharmaceuticals and Astra Industrial Group. Regional players are BinDawood Holding, Al Hammadi Holding, Al-Nahdi Medical Company and Dallah Healthcare Holding. Tamer Group is listed as a direct peer.
Does Al Mojil Drug Co. have an API?
No public API is recorded for Al Mojil Drug Co..
What industry is Al Mojil Drug Co. in?
Al Mojil Drug Co.'s product category is Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 42421 and its SIC code is 5122.